Ron Ellis
Director/Board Member chez GeneQuine Biotherapeutics GmbH
Profil
Ron Ellis is currently a Director at GeneQuine Biotherapeutics GmbH and CarthroniX, Inc. He was formerly a Chief Strategy Officer at Pacira Biosciences, Inc. Dr. Ellis holds an MBA from St. Joseph's University and a doctorate from Philadelphia College of Osteopathic Medicine.
Postes actifs de Ron Ellis
| Sociétés | Poste | Début |
|---|---|---|
GeneQuine Biotherapeutics GmbH
 GeneQuine Biotherapeutics GmbH Pharmaceuticals: MajorHealth Technology GeneQuine Biotherapeutics GmbH develops gene therapy drugs for the treatment of osteoarthritis. Its gene therapy is to introduce genetic material into the patient's own cells in the body. The firm's genetic material will make the cells to produce a therapeutic protein. The company was founded by Kilian Guse and Stanislav Plutizki in October 2012 and is headquartered in Hamburg, Germany. | Director/Board Member | - |
CarthroniX, Inc.
 CarthroniX, Inc. Medical/Nursing ServicesHealth Services CarthroniX, Inc. is a private company that is focused on developing small molecules to stimulate the growth and regeneration of articular cartilage in joints. The company is based in Lancaster, CA. The company's patented small molecule CX-1 activates a regenerative pathway that results in cartilage proliferation, cellular migration, and deposition of cartilaginous matrix. | Director/Board Member | - |
Anciens postes connus de Ron Ellis
| Sociétés | Poste | Fin |
|---|---|---|
| PACIRA BIOSCIENCES, INC. | Corporate Officer/Principal | - |
Formation de Ron Ellis
| St. Joseph's University | Masters Business Admin |
| Philadelphia College of Osteopathic Medicine | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| PACIRA BIOSCIENCES, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
GeneQuine Biotherapeutics GmbH
GeneQuine Biotherapeutics GmbH Pharmaceuticals: MajorHealth Technology GeneQuine Biotherapeutics GmbH develops gene therapy drugs for the treatment of osteoarthritis. Its gene therapy is to introduce genetic material into the patient's own cells in the body. The firm's genetic material will make the cells to produce a therapeutic protein. The company was founded by Kilian Guse and Stanislav Plutizki in October 2012 and is headquartered in Hamburg, Germany. | Health Technology |
CarthroniX, Inc.
CarthroniX, Inc. Medical/Nursing ServicesHealth Services CarthroniX, Inc. is a private company that is focused on developing small molecules to stimulate the growth and regeneration of articular cartilage in joints. The company is based in Lancaster, CA. The company's patented small molecule CX-1 activates a regenerative pathway that results in cartilage proliferation, cellular migration, and deposition of cartilaginous matrix. | Health Services |
